Weight Management

By JONEL ALECCIA - AP Health Writer A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.The U.S. Food and Drug…

A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | ReutersNovo Nordisk's obesity drug Wegovy slashed the risk of serious heart…

The Eli Lilly logo is shown on one of the company's offices in San Diego, California, September 17, 2020.Mike Blake | ReutersAn Eli Lilly experimental drug helped patients lose about 26% of their weight on average following extended use or…

Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy.Stefan Trumpf | Picture Alliance | Getty ImagesU.K. health authorities on Wednesday said they are reviewing…

Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.Cristina Arias | Cover | Getty ImagesEli Lilly on Friday said it will acquire Versanis, a privately held obesity drug maker, for up to $1.93 billion to…

In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California.Mario Tama | Getty ImagesThe European Union's drug regulator on Tuesday said it has broadened an…

A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023.Jim Vondruska | ReutersOnly around one-third of patients prescribed weight loss drugs such as Novo…

In this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty ImagesPeople on diabetes and weight loss drugs such as Novo Nordisk's Ozempic and…

An Eli Lilly & Co. logo is seen on a box of insulin medication in this arranged photograph at a pharmacy in Princeton, Illinois.Daniel Acker | Bloomberg | Getty ImagesDrugmakers are jockeying to capitalize on the next major innovation…

Novo Nordisk said that it was cutting the supply of some doses of its popular obesity drug in the U.S. as it struggles to keep up with surging demand.Liselotte Sabroe | Afp | Getty ImagesNovo Nordisk's high-dose experimental obesity pill…